Enter your login e-mail to the account
Search
Search parameters
Search results
- Acute disseminated encephalomyelitis or multiple sclerosis?
MUDr. Pavel Potužník, Ph.D., MUDr. Ing. Radek Tupý, Ph.D., MUDr. Eliška Kopáčová, MUDr. Marek Peterka
(4/2024, Case reports ) - Sphingosine-1-phosphate receptor modulators in the treatment of early phase multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník, Ph.D.
(5/2023, Review articles ) - Improved cognitive function and employment in patients with relapsing multiple sclerosis treated with ocrelizumab
MUDr. Marek Peterka
(4/2023, Review articles ) - Long-term efficacy and safety of ofatumumab in the treatment of multiple sclerosis
MUDr. Marek Peterka
(6/2022, Review articles ) - Shorter infusion of ocrelizumab in the treatment of multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2021, Review articles ) - Siponimod: the first drug in secondary progressive multiple sclerosis in clinical practice
MUDr. Pavel Potužník, MUDr. Marek Peterka
(4/2021, Case reports ) - Long-term management of oral cladribine treatment in multiple sclerosis
MUDr. Radek Ampapa, MUDr. Michal Dufek, Ph.D., MUDr. Pavel Hradílek, Ph.D., MUDr. Ivana Kovářová, Prof. MUDr. Jan Mareš, Ph.D., MUDr. Alena Martinková, MUDr. Marek Peterka , doc. MUDr. Pavel Štourač, Ph.D., MUDr. Aleš Tvaroh, Ph.D., MUDr. Marta Vachová, prof. MUDr. Martin Vališ, Ph.D., FEAN
(3/2021, Review articles ) - Early diagnosis and treatment of multiple sclerosis
MUDr. Marek Peterka , MUDr. Pavel Potužník
(2/2021, Review articles ) - Longterm safety of Ocrelizumab in Multiple Sclerosis treatment
MUDr. Marek Peterka , MUDr. Pavel Potužník
(4/2020, Review articles ) - A new era of multiple sclerosis treatment
MUDr. Marek Peterka
(4/2019, Review articles ) - Monoklonální protilátky v léčbě roztroušené sklerózy
MUDr. Marek Peterka , MUDr. Zdeněk Kasl, Ph.D.
(2/2018, Pharmacotherapy ) - Escalation vs. induction therapy in multiple sclerosis
MUDr. Marek Peterka
(4/2017, Review articles )